Federal contractor profile

BIOINTRON BIOLOGICAL USA INC

UEI K4YNFPMLJSJ4CAGE 98RQ4

Small Business

Overview

Legal name: BIOINTRON BIOLOGICAL USA INC
Registered location: METUCHEN, NJ, USA
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: Sep 1, 2026

Read company summary

BIOINTRON BIOLOGICAL USA INC is associated with UEI K4YNFPMLJSJ4 and CAGE 98RQ4 in public federal records. AcornBids currently links 2 prime awards totaling $99.7K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Analytical Laboratory Instrument Manufacturing; Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists METUCHEN, NJ, USA.

At a glance

Lifetime prime obligations$99.7K

Prime awards2

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: BIOINTRON BIOLOGICAL USA INC
UEI: K4YNFPMLJSJ4
CAGE: 98RQ4
Registered address: 20 BRIDGE ST, METUCHEN, NJ, 08840, USA
Registration status: E
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Jun 2, 2025
Initial registration: Jan 19, 2022
Entity start: May 7, 2021
SAM updated: May 29, 2026
Registration expires: May 29, 2026
Fiscal year end: Dec 31
Place of incorporation: NJ, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75N98026P01504NICHD: NANOBODY SCREENING FOR ANTI-HUMAN NPR-C VHH ANTIBODY DISCOVERY. PROJECT ID: 9PKWNH001. REFERENCE QUOTE: Q260612_9PKWNH.	Department of Health and Human Services	$49.8K	Sep 4, 2026	Sep 3, 2027
75N93024P00841ANTIBODY EXPRESSION SERVICE	Department of Health and Human Services	$49.9K	Jul 12, 2024	Jul 11, 2025

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

NICHD: NANOBODY SCREENING FOR ANTI-HUMAN NPR-C VHH ANTIBODY DISCOVERY. PROJECT ID: 9PKWNH001. REFERENCE QUOTE: Q260612_9PKWNH.

Department of Health and Human Services$49.8K obligationsEnds Sep 3, 202760% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	May 29, 2026
Source loaded	Sep 26, 2026
Initial registration	Jan 19, 2022
Entity start	May 7, 2021

Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
GLORIA GAO	Government business	Contact method not published	SAM registration	Not available
GLORIA GAO	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source